Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Biotechnology

Health & Wellness

Health Care

Life Sciences

Minervax

Minervax's headquarters in Hellerup, Denmark

Per Fischer

Bjørn Kantsø

Hans Henrik Chrois Christensen

Karina Nymark

Bengt Johansson Lindbom

Terri Genthe

Lidia Oostvogels

Emmanuelle Coutanceau

Gerd Zettlmeissl

Sten Verland

Jonas Brambeck

Karl Nägler

Kabeer Aziz

Christopher Gagliardi

Veronica Gambillara Fonck

Bita Sehat

The Clinical Development and Research team at Minervax is responsible for designing, implementing, and managing clinical trials to assess the safety and efficacy of the novel Group B Streptococcus vaccine. This multidisciplinary team collaborates on research initiatives, regulatory submissions, and operational strategies, ensuring compliance with industry standards while advancing vaccine development from preclinical through clinical phases. Their efforts are pivotal in bringing innovative solutions to market and improving public health.

Clinical Development and Research

This department comprises executives responsible for guiding the strategic direction and overall management of the organization.

Leadership

This department oversees the strategic direction and operational management of the organization.

Executive Leadership

The Leadership Team at Minervax drives the strategic vision and direction for the company, ensuring the successful development of its innovative vaccine against Group B Streptococcus. Comprising the CEO, CSO, and CTO, the team focuses on overseeing research initiatives, regulatory compliance, and commercial strategies, while fostering collaboration across departments to achieve milestones in biotechnology development.

Leadership Team

This department ensures product quality through rigorous testing and compliance processes while managing IT operational effectiveness.

Quality Assurance Operations

The Regulatory Affairs and Quality Assurance team at Minervax is responsible for ensuring that the development and manufacturing processes of the Group B Streptococcus vaccine comply with all regulatory requirements and quality standards. This team collaborates with various departments to prepare documentation for regulatory submissions, oversee quality control measures, and maintain compliance throughout the product lifecycle to facilitate safe and effective vaccine release.

Minervax

Org chart

Board & advisors

Teams

Clinical Development and Research

Leadership

Executive Leadership

Leadership Team

Quality Assurance Operations

Regulatory Affairs and Quality Assurance

Offices

Minervax

Org chart

Board & advisors

Teams

Clinical Development and Research

Leadership

Executive Leadership

Leadership Team

Quality Assurance Operations

Regulatory Affairs and Quality Assurance

Offices

Related companies